This morning, Merck (NYSE:MRK) announced third quarter earnings of 85 cents per share, ex-items, narrowly beating Wall Street estimates of 82 cents per share. Though, with the stock trading lower in the pre-market, it appears traders are more focused on the top line miss by the company. Revenue for the third quarter came in at $11.12 billion, just short of the consensus estimate of $11.24 billion.
Merck's news is sure to impact a number of ETFs heavily weighted towards the pharmaceutical giant. The Pharmaceutical HOLDRS ETF (AMEX:PPH) holds 18.47% of its portfolio in Merck, second only to Johnson & Johnson (NYSE:JNJ) and the Health Care Select Sector SPDR Fund (AMEX:XLV) holds 9.37% of its portfolio in Merck, the third largest holding behind Johnson & Johnson and Pfizer (NYSE:PFE). For a full list of ETFs holding shares of Merck, visit the ETFs Containing MRK page.
Today to be alerted when we launch, and we'll offer you a 20% discount on your first year of service! The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.
This Article's Word Cloud:AMEXETFsGrowthJohnsonMerckNYSEPfizerRevenueSPDRSectorStreetThisalertedallowsassetbeatingbehindbillioncamecentscommoditiesdesignedearningsestimatesflexibilityfollowholdingholdslevellinelistlowermarketnarrowlynumberportfolioprogramquarterregionssecondsectorsshareshortthirdtradingvisitweightedwhereverwithyour
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.